Adaptive Radiotherapy Software Market Report 2025

The adaptive radiotherapy software market size has grown rapidly in recent years. It will grow from $0.62 billion in 2024 to $0.7 billion in 2025 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period is attributed to increasing regulatory approvals, rising use of combined imaging modalities, growing adoption of image-guided radiotherapy, the need to minimize radiation exposure to healthy tissues, and wider availability of cloud-based radiotherapy solutions.

The adaptive radiotherapy software market size is expected to see rapid growth in the next few years. It will grow to $1.2 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth in the forecast period is driven by greater adoption of precision radiotherapy techniques, rising demand for personalized cancer treatment plans, increased investment in oncology healthcare infrastructure, higher prevalence of cancer, and growing awareness among clinicians. Key trends in the forecast period include advancements in imaging technologies, development of cloud-based software platforms, integration of image-guided radiotherapy technologies, improvements in automation algorithms, and incorporation of multi-modality imaging data.

The increasing incidence of cancer is expected to drive the expansion of the adaptive radiotherapy software market. Cancer cases refer to the number of individuals diagnosed with cancer within a specific population over a set period. The rise in cancer cases is primarily due to aging populations, as the likelihood of accumulating genetic mutations increases with age, resulting in more frequent diagnoses. Adaptive radiotherapy software addresses this challenge by modifying radiation treatments in real time based on changes in tumor size, shape, and patient anatomy. This approach improves treatment precision, enhances tumor targeting, and reduces harm to surrounding healthy tissue. For example, in October 2022, Macmillan Cancer Support, a charitable organization in the United Kingdom that offers comprehensive support to individuals affected by cancer, reported that the number of people living with cancer in the country is projected to reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040, up from an estimated 3 million currently. As a result, the growing number of cancer cases is contributing to the demand for adaptive radiotherapy software.

Leading companies in the adaptive radiotherapy software market are focusing on technological innovations such as artificial intelligence-powered adaptive CT-Linac systems to improve real-time tumor targeting, treatment precision, and patient outcomes. An artificial intelligence-powered adaptive CT-Linac is a radiation therapy system that combines computed tomography imaging with a linear accelerator, utilizing artificial intelligence to adapt radiation delivery during treatment based on the tumor’s evolving characteristics. For example, in May 2024, Elekta AB, a pharmaceutical and medical technology company based in Sweden, introduced Evo, a system designed to provide highly accurate and efficient radiotherapy. Evo delivers personalized cancer radiation treatment by offering advanced imaging capabilities enhanced by artificial intelligence, allowing clinicians to clearly visualize tumors and make treatment adjustments either during or between sessions. This technology aims to improve accuracy, reduce adverse effects, and enhance patient quality of life, while offering clinics the flexibility to implement these advancements at a pace that suits their operations.

In April 2024, GE Healthcare Technologies Inc., a medical diagnostics company based in the United States, acquired MIM Software Inc. for an undisclosed amount. This acquisition is intended to support GE Healthcare’s precision care strategy by incorporating MIM Software’s artificial intelligence-powered imaging analysis and digital workflow tools, thereby improving the delivery of precise, coordinated, and efficient care across various disease areas. MIM Software Inc. is a United States-based software company that specializes in adaptive radiotherapy solutions.

Major players in the adaptive radiotherapy software market are Siemens Healthineers AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., United Imaging Healthcare Co. Ltd., Brain lab AG, Accuray Incorporated, RaySearch Laboratories AB, ViewRay Inc., C-RAD AB, Standard Imaging Inc., LAP GmbH Laser Applikationen, Oncology Systems Limited, DOSIsoft SA, Mirada Medical Ltd., Limbus AI, MagnetTx Oncology Solutions Ltd., Spectronic Medical AB, Akesis Inc.

North America was the largest region in the adaptive radiotherapy software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adaptive radiotherapy software report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the adaptive radiotherapy software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Adaptive radiotherapy software is a specialized tool in radiation oncology that allows real-time or near-real-time adjustments to radiotherapy treatment plans based on changes in a patient’s anatomy, tumor size, or position during treatment. It combines imaging data, including CT, MRI, or cone-beam CT, with treatment planning systems to optimize radiation delivery, enhance tumor targeting, and reduce exposure to surrounding healthy tissues.

The primary component types of adaptive radiotherapy software are software and services. Software includes adaptive radiotherapy programs and platforms used for planning, monitoring, and delivering precise radiation treatments. These solutions are deployed through on-premises and cloud-based platforms. Applications include prostate cancer, head and neck cancer, breast cancer, lung cancer, and other conditions. End-users include hospitals, cancer treatment centers, research institutes, and related healthcare facilities.

The adaptive radiotherapy software market research report is one of a series of new reports that provides adaptive radiotherapy software market statistics, including adaptive radiotherapy software industry global market size, regional shares, competitors with an adaptive radiotherapy software market share, detailed adaptive radiotherapy software market segments, market trends and opportunities, and any further data you may need to thrive in the adaptive radiotherapy software industry. This adaptive radiotherapy software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adaptive radiotherapy software market consists of revenues earned by entities by providing services such as imaging data processing services, radiation dose adjustment services, real-time monitoring services, clinical workflow customization services, and regulatory compliance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The adaptive radiotherapy software market also includes sales of imaging systems, treatment planning systems, verification tools, deformable registration tools, oncology information systems, and dose tracking systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.